Stryker combo product
This article was originally published in The Gray Sheet
Executive Summary
Simplex P with tobramycin antibiotic bone cement 510(k) clearance is Stryker's first offering of a drug/device combination product in the U.S. Simplex P is indicated for patients undergoing the second stage of a two-stage revision for a total joint procedure after an active infection subsides. Demand in the orthopedic surgeon community for a pre-blended antibiotic bone cement will aid market adoption, Stryker notes...